Magnus Gren1, Pashtun Shahim1,2, Ronald Lautner1, David H Wilson3, Ulf Andreasson1, Niklas Norgren4, Kaj Blennow1, Henrik Zetterberg1,5. 1. a Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital , Mölndal , Sweden. 2. b Department of Neurosurgery , University Hospital , Linköping , Sweden. 3. c Quanterix , Lexington , MA , USA. 4. d UmanDiagnostics , Umeå , Sweden. 5. e Department of Molecular Neuroscience , Reta Lila Weston Laboratories, UCL Institute of Neurology , London , UK.
Abstract
OBJECTIVE: To determine whether transient hypoxia during breath-hold diving causes neuronal damage or dysfunction or alters amyloid metabolism as measured by certain blood biomarkers. DESIGN: Sixteen divers competing in the national Swedish championship in breath-hold diving and five age-matched healthy control subjects were included. Blood samples were collected at baseline and over a course of 3 days where the divers competed in static apnea (STA), dynamic apnea without fins (DYN1) and dynamic apnea with fins (DYN2). MAIN OUTCOMES: Biomarkers reflecting brain injury and amyloid metabolism were analysed in serum (S-100β, NFL) and plasma (T-tau, Aβ42) using immunochemical methods. RESULTS: Compared to divers' baseline, Aβ42 increased after the first event of static apnea (p = 0.0006). T-tau increased (p = 0.001) in STA vs baseline and decreased after one of the dynamic events, DYN2 (p = 0.03). Further, T-tau correlated with the length of the apneic time during STA (ρ = 0.7226, p = 0.004) and during DYN1 (ρ = 0.66, p = 0.01). CONCLUSION: The findings suggest that transient hypoxia may acutely increase the levels of Aβ42 and T-tau in plasma of healthy adults, further supporting that general hypoxia may cause mild neuronal dysfunction or damage and stimulate Aβ production.
OBJECTIVE: To determine whether transient hypoxia during breath-hold diving causes neuronal damage or dysfunction or alters amyloid metabolism as measured by certain blood biomarkers. DESIGN: Sixteen divers competing in the national Swedish championship in breath-hold diving and five age-matched healthy control subjects were included. Blood samples were collected at baseline and over a course of 3 days where the divers competed in static apnea (STA), dynamic apnea without fins (DYN1) and dynamic apnea with fins (DYN2). MAIN OUTCOMES: Biomarkers reflecting brain injury and amyloid metabolism were analysed in serum (S-100β, NFL) and plasma (T-tau, Aβ42) using immunochemical methods. RESULTS: Compared to divers' baseline, Aβ42 increased after the first event of static apnea (p = 0.0006). T-tau increased (p = 0.001) in STA vs baseline and decreased after one of the dynamic events, DYN2 (p = 0.03). Further, T-tau correlated with the length of the apneic time during STA (ρ = 0.7226, p = 0.004) and during DYN1 (ρ = 0.66, p = 0.01). CONCLUSION: The findings suggest that transient hypoxia may acutely increase the levels of Aβ42 and T-tau in plasma of healthy adults, further supporting that general hypoxia may cause mild neuronal dysfunction or damage and stimulate Aβ production.
Entities:
Keywords:
Amyloid; blood biomarkers; breath-hold diving; hypoxia; neuroaxonal injury; tau
Authors: Anders Rosén; Nicklas Oscarsson; Andreas Kvarnström; Mikael Gennser; Göran Sandström; Kaj Blennow; Helen Seeman-Lodding; Henrik Zetterberg Journal: Diving Hyperb Med Date: 2019-06-30 Impact factor: 0.887
Authors: Damian M Bailey; Anthony R Bain; Ryan L Hoiland; Otto F Barak; Ivan Drvis; Christophe Hirtz; Sylvain Lehmann; Nicola Marchi; Damir Janigro; David B MacLeod; Philip N Ainslie; Zeljko Dujic Journal: J Cereb Blood Flow Metab Date: 2022-01-21 Impact factor: 6.960
Authors: Anders Rosén; Mikael Gennser; Nicklas Oscarsson; Andreas Kvarnström; Göran Sandström; Helen Seeman-Lodding; Joel Simrén; Henrik Zetterberg Journal: Eur J Appl Physiol Date: 2022-02-10 Impact factor: 3.346
Authors: Jaime Ramos-Cejudo; Thomas Wisniewski; Charles Marmar; Henrik Zetterberg; Kaj Blennow; Mony J de Leon; Silvia Fossati Journal: EBioMedicine Date: 2018-01-31 Impact factor: 8.143